Back to Search
SUSAN GUBA, MD
MD
Hematology & Oncology Physician
NPI: 1558350462Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
L1056(TX)
Research & Publications (2)
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
PMID 19632943·Clin Lung Cancer·2009
3-trial
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.
PMID 17440727·Cancer Chemother Pharmacol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8440 WALNUT HILL LN, STE 600
DALLAS, TX 75231 - Phone
- (214) 739-1706
Quick Facts
- NPI
- 1558350462
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 2
Are you this provider?
Claim Your Profile